American Diabetes Association’s 80th Annual Scientific Sessions: #ADA2020

The biggest diabetes conference of the year is taking place virtually and Beyond Type 2 is reporting live! Learn more, stay tuned.

Medicare Part D Senior Savings Model Caps Insulin Costs at $35 per Month

The Senior Savings Model caps out of pocket insulin costs at $35 per month for seniors enrolled in eligible plans.

England’s NHS Releases Study on Risk of COVID-19 for People with Diabetes

This week, the National Health Service (NHS) in England released the first study of its kind, breaking down COVID-19 mortality risk by type of diabetes.

ADA 2019 – American Diabetes Association’s 79th Annual Conference

The Beyond Type 2 team's live coverage of the American Diabetes Association's 79th Annual Conference.

Silver Linings During COVID-19

Here's a rundown of positive things happening around the world that you might have missed because it's important to focus on the good news, too!

FreeStyle Libre Approved by FDA for Hospitalized Patients During COVID-19 Pandemic

Abbott's FreeStyle Libre 14 day system will allow doctors to remotely monitor their patient's glucose levels.

New Program Offers $35 Monthly Copays for Lilly Insulins

Eli Lilly announced a new program that allows people in the US to fill their monthly prescription of Lilly insulin for $35 per month with a copay card.

Senseonics Suspends Commercial US Sales of Eversense in Response to COVID-19

On March 26, Senseonics suspended all commercial sales of the Eversense continuous glucose monitor (CGM) in the United States.

The Diabetes Disaster Response Coalition Coronavirus Response

On March 12, the Diabetes Disaster Response Coalition (DDRC) circulated an update to coalition members in response to coronavirus (COVID-19). Here are the steps the organization is taking and other important information to note.

New Medicare Plan Will Cap Insulin Copays at $35

Today, the Centers for Medicare & Medicaid Services (CMS) launched a new plan for some Medicare Part D participants to pay a maximum $35 copay for their monthly supply of insulin.